Comparison of risk and predictors for early radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with radiotherapy with or without surgery

被引:35
|
作者
Dang, Jun [1 ]
Li, Guang [1 ]
Zang, Shuang [2 ]
Zhang, Shuo [1 ]
Yao, Lei [1 ]
机构
[1] China Med Univ, Hosp 1, Dept Radiat Oncol, Shenyang 110001, Peoples R China
[2] China Med Univ, Dept Nursing, Shenyang 110001, Peoples R China
关键词
Locally advanced non-small cell lung cancer; Radiation pneumonitis; Predictor; Three-dimensional conformal radiotherapy; Postoperative radiotherapy; Chemotherapy; THERAPY; TOXICITY; METAANALYSIS; IRRADIATION; INJURY;
D O I
10.1016/j.lungcan.2014.10.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: To investigate risk and predictors for radiation pneumonitis (RP) and tolerance of lung to radiation in patients treated with thoracic radiotherapy (RT) with or without surgery. Methods and materials: A total of 433 consecutive patients with locally advanced non-small cell lung cancer were followed after three-dimensional conformal radiotherapy. Among them 284 received RT without surgical intervention and 149 received postoperative radiotherapy (PORT). RP was graded according to Common Terminology Criteria for Adverse Events version 4.0. Results: The rate of grade >= 2 and grade >= 3 RP was 50 and 16% in the PORT group compared with 38 and 9% in the non-surgical group (p<0.05 for each comparison). The lung volume was significantly smaller in PORT group than in no-surgical group (3181 +/- 915 cm(3) vs. 4010 +/- 1120 cm(3),p<0.05). Age, chemotherapy, mean lung dose (MLD) and planning target volume (PTV) were predictors of RP for both non-surgical group and PORT group. Mean heart dose (MHD) predicted RP in PORT group only (OR=1.28, p=0.003). Among patients who developed RP, V20, MLD, and MHD were significantly lower in PORT group than in no-surgical group (p<0.05 for each comparison). Conclusions: Except MHD predicting RP in PORT group only, most of predictors for RP were consistent in patients treated with RT with or without surgery. Patients receiving PORT had a higher risk of RP than patients receiving RT without surgery did, possibly due to decreased lung volume and lower tolerance of lung to chemoradiotherapy. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:329 / 333
页数:5
相关论文
共 50 条
  • [1] Predictors of pneumonitis in locally advanced non-small cell lung cancer patients treated on the Pacific regimen
    Gao, R. W.
    Prodduturvar, P.
    Day, C. N.
    Harmsen, W. S.
    Olivier, K. R.
    Merrell, K. W.
    Garces, Y. I.
    James, S.
    McKone, T. K.
    Ng, L.
    Smith, R. S.
    Stockham, A.
    Wilson, Z.
    Molina, J. R.
    Leventakos, K.
    Dimou, A.
    Mansfield, A. S.
    Amundson, A. C.
    Owen, D.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S942 - S942
  • [2] The Impact of Radiation Pneumonitis on Prognosis of Patients with Locally Advanced Non-Small Cell Lung Cancer Treated with Chemoradiotherapy
    Akita, T.
    Baba, K.
    Tanaka, H.
    Fujioka, I.
    Suzuki, S.
    Tabe, C.
    Shiratori, T.
    Ishioka, Y.
    Itoga, M.
    Taima, K.
    Yokouchi, J.
    Hasegawa, Y.
    Takanashi, S.
    Tasaka, S.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S636 - S636
  • [3] Radiation pneumonitis in patients with locally advanced non-small-cell lung cancer treated with concurrent radiotherapy and gemcitabine
    Michel, Rosa M.
    Gallardo-Rincon, Dolores
    Villarreal-Garza, Cynthia
    Astorga-Ramos, Alma
    Zamora, Jesus
    Martinez-Barrera, Luis
    de la Garza, Jaime
    Arrieta, Oscar
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S846 - S847
  • [4] Dosimetric predictors of pneumonitis in locally advanced non-small cell lung cancer patients treated with chemoradiation followed by durvalumab
    Gao, Robert W.
    Day, Courtney N.
    Yu, Nathan Y.
    Bush, Aaron
    Amundson, Adam C.
    Prodduturvar, Pranitha
    Majeed, Umair
    Butts, Emily
    Oliver, Thomas
    Schwecke, Anna J.
    Moffett, Jenesse N.
    Routman, David M.
    Breen, William G.
    Potter, Ashley L.
    Rivera-Concepcion, Joel
    Hoppe, Bradford S.
    Schild, Steven E.
    Sio, Terence T.
    Lou, Yanyan
    Ernani, Vinicius
    Ko, Stephen
    Olivier, Kenneth R.
    Merrell, Kenneth W.
    Garces, Yolanda, I
    Manochakian, Rami
    Harmsen, William S.
    Leventakos, Konstantinos
    Owen, Dawn
    [J]. LUNG CANCER, 2022, 170 : 58 - 64
  • [5] Predictors of grade ≥ 2 and grade ≥ 3 radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with three-dimensional conformal radiotherapy
    Dang, Jun
    Li, Guang
    Ma, Lianghua
    Diao, Rao
    Zang, Shuang
    Han, Chong
    Zhang, Shuo
    Yao, Lei
    [J]. ACTA ONCOLOGICA, 2013, 52 (06) : 1175 - 1180
  • [6] Radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent radiotherapy and gemcitabine after induction with gemcitabine and carboplatin
    Michel, R. M.
    Gallardo-Rincon, D.
    Villarreal-Garza, C.
    Astorga-Ramos, A.
    Zamora, J.
    Martinez-Barrera, L.
    de la Garza, J.
    Arrieta, O.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [7] Immune Parameters as Predictors of Pneumonitis and Survival in Locally Advanced Non-Small Cell Lung Cancer Treated With Chemoradiation
    Ho, Quoc-Anh
    Qi, Lihong
    Rao, Shyam S.
    Daly, Megan E.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (02): : E36 - E37
  • [8] Risk and predictors for early radiation pneumonitis in patients with stage III non-small cell lung cancer treated with concurrent or sequential chemoradiotherapy
    Jun Dang
    Guang Li
    Shuang Zang
    Shuo Zhang
    Lei Yao
    [J]. Radiation Oncology, 9
  • [9] Predictors of Pneumonitis in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Definitive Chemoradiation Followed by Consolidative Durvalumab
    Diamond, Brett H.
    Belani, Neel
    Masel, Rebecca
    DeCarli, Kathryn
    DiPetrillo, Thomas
    Hepel, Jaroslaw T.
    Azzoli, Christopher G.
    Khurshid, Humera
    Abbas, Abbas
    Koffer, Paul P.
    [J]. ADVANCES IN RADIATION ONCOLOGY, 2023, 8 (02)
  • [10] Risk and predictors for early radiation pneumonitis in patients with stage III non-small cell lung cancer treated with concurrent or sequential chemoradiotherapy
    Dang, Jun
    Li, Guang
    Zang, Shuang
    Zhang, Shuo
    Yao, Lei
    [J]. RADIATION ONCOLOGY, 2014, 9